1-es típusú cukorbetegség: vizsgálatok itt: Argentína
6 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Buenos Aires, Córdoba, Mar del Plata, Salta, San Miguel de Tucumán, Santa Fe
- Életkor
- 1 év to 25 év
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - 3. fázisNot yet taking people in ArgentínaA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero
- Életkor
- 18 év and over
- People
- 2500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - 3. fázisNot yet taking people in ArgentínaAMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Where
- Bahía Blanca, Buenos Aires, CABA, Ciudad Autonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Godoy Cruz, Mar del Plata, Rosario, San Juan, San Miguel de Tucumán, San Rafael
- Életkor
- 45 év and over
- People
- 1778 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07797335 - No phaseTaking peopleStudy of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
- Where
- Buenos Aires
- Életkor
- 18 év and over
- People
- 145
- Run by
- Hospital Italiano de Buenos Aires
See details and how to joinNCT07621419